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Purpose: The membrane frizzled-related protein (MFRP) has been proposed as a probable candidate gene for extreme
hyperopia and nanophthalmos, which are factors for angle-closure glaucoma. The purpose of our study was to investigate
whether there are significant associations between angle-closure glaucoma and sequence variants in the MFRP gene
reported previously in Taiwanese subjects.
Methods: Genomic DNA was collected from 63 subjects with angle-closure glaucoma and 66 age-matched and gender-
matched controls without angle-closure glaucoma. Three sequence variants were detected by polymerase chain reaction
(PCR) and direct sequencing in all of the cases and controls.
Results: None of the three sequence variants showed a significant result in terms of association with disease. The pairwise
linkage disequilibrium (LD) mapping confirmed that these alleles have a comparatively strong LD index greater than 0.7
for D' and greater than 0.4 for r2 at these polymorphisms. However, we found there were no statistical associations between
any of the three sequence variants located on MFRP and angle-closure glaucoma.
Conclusions: In our pilot study, variations that we tested in MFRP were not associated with the development of acute
angle-closure glaucoma in Taiwanese subjects.
Angle-closure  glaucoma  is  an  important  cause  of
blindness in the Asian population particularly in those of
Chinese and Taiwanese descent and may be acute, sub-acute,
or chronic [1]. It has been established that primary angle-
closure glaucoma (PACG) is associated with certain biometric
ocular  features  such  as  shallow  anterior  chamber  [2,3],
increased thickness of the lens [4], and short axial length [5].
Such patients usually have a hyperopic refractive error [6].
The  mechanisms  involved  in  the  pathophysiology  and
development  of  PACG  are  complicated  and  involve  the
anatomy of the anterior chamber angle as well as the spatial
and  anatomic  relationships  between  the  lens,  iris,  ciliary
processes, and vitreous [7]. The pathophysiology of PACG
usually involves an increase in lens thickness during the aging
process, often in the setting of a relatively small eye and a
shallow  anterior  chamber.  By  contrast,  myopic  eyes  are
typically longer and possess a thin sclera, particularly at the
posterior pole. The human sclera of eyes with PACG and axial
myopia  undergo  active  remodeling  and  result  in  either
excessive  shortening  or  elongation  of  the  axial  length.
Biochemical assays of highly myopic eyes show markedly
reduced  amounts  of  markers  for  collagen  and
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glycosaminoglycans when compared with the similar region
of sclera in emmetropic eyes [8].
Nanophthalmos, sometimes referred to as “simple (or
pure)  microphthalmos”  [9],  is  a  relatively  rare  condition
characterized by a small eye in the absence of any systemic
abnormalities.  Nanophthalmic  eyes  show  considerable
thickening of both the choroidal vascular bed and scleral coat,
which provide nutritive and structural support for the retina.
The thickening of these tissues is a general feature of axial
hyperopia  whereas  the  opposite  occurs  in  myopia.  Both
autosomal  recessive  and  autosomal  dominant  inheritances
have been reported for nanophthalmos [10,11]. The major
clinical characteristics of the nanophthalmic eye include a
short axial length, a high degree of hyperopia, a high lens/eye
volume ratio, and a small corneal diameter [12,13]. The strong
association of angle-closure glaucoma with nanophthalmos is
thought to result from the ocular anatomic abnormalities seen
in this condition [9,12].
The membrane frizzled-related protein gene (MFRP) is
located  on  human  chromosome  11q23.3  and  is  expressed
predominantly  in  the  retinal  pigment  epithelial  cells  and
ciliary epithelial cells of the eye and at a lower level in the
brain  [14,15].  Recessive  nanophthalmos  is  related  to  this
unique locus, and four independent mutations in MFRP have
been identified. This gene is not critical for retinal function as
patients entirely lacking MFRP can still have good corrected
vision,  produce  clinically  normal  electroretinograms,  and
show  only  modest  anomalies  in  the  dark  adaptation  of
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1673photoreceptors.  MFRP  appears  primarily  devoted  to
regulating axial length of the eye. It remains to be determined
whether natural variation in its activity plays a role in any
common refractive error.
In  this  report,  we  hypothesized  that  MFRP  plays  an
important  role  in  ocular  axial  length  regulation  of  angle-
closure  glaucoma.  We  undertook  a  case-control  study  to
identify potential sequence variants and their association with
acute angle-closure glaucoma.
METHODS
Patients: Unrelated Taiwanese subjects with acute PACG and
unrelated control subjects with normal eyes were recruited at
the National Taiwan University Hospital (Taipei, Taiwan) and
Mackay Memorial Hospital (Taipei, Taiwan). All participants
had similar social backgrounds and were from the local ethnic
Han Chinese population with no ethnic subdivision. Informed
consent was obtained from all subjects. This project had the
approval  of  the  institutional  review  board  (IRB)/ethics
committees  of  both  hospitals  and  was  performed  in
accordance with the World Medical Association's Declaration
of Helsinki.
Patients were eligible for study participation if their acute
PACG met the following diagnostic criteria: (1) the presence
of at least two symptoms: eye pain, headache, blurred vision,
and  vomiting;  (2)  the  presence  of  the  following  signs:
conjunctival congestion, a mid-dilated unreactive pupil, and
corneal edema; (3) 270 degree or greater of anterior chamber
angle closure on gonioscopic examination; and (4) intraocular
pressure (IOP)>40 mmHg by Perkins handheld applanation
tonometry. All of these criteria were in compliance with the
International Society for Geographical and Epidemiological
Ophthalmology  (ISGEO)  classification  of  angle-closure
glaucoma by Foster et al. [16]. Control subjects did not have
a history of any of the aforementioned symptoms and signs.
Every participant received a complete ocular examination,
which  included  retinoscopy,  slit-lamp  evaluation  of  the
anterior segment, measurement of intraocular pressure, axial
length measurement (Sonomed Ultrasound A-1500; Sonomed
Inc., Lake Success, NY), keratometry measurement, fundus
examination, and detailed recording of the health and degree
of cupping of the optic nerve head.
DNA  Extraction:  After  informed  consent  was  obtained,
10-15 ml of venous blood was drawn from each participant,
and total genomic DNA was extracted. DNA was purified
from lymphocyte pellets according to described procedures
using the Puregene kit (Gentra Systems, Minneapolis, MN) or
the phenol-chloroform extraction method [17].
Direct  DNA  sequencing:  Screening  was  performed  for
possible  mutations  or  single  nucleotide  polymorphisms
(SNPs) in exons 4, 5, and 10 of MFRP, which have been
previously  studied  to  find  the  association  with  extreme
hyperopia [18,19]. Exon 4 and exon 5 were amplified with a
forward primer (AGG ACC CAG CTC CTC TGA AC) and
reverse primer (CTT CCT CGG TTA GCC CTT CT). Exon
10 was amplified with another forward primer (AGG GCT
GGT GCC CAG AAC AGC TGT CTG CTT T) and reverse
primer (ATA CCT ACA CCC CCA GTA CCC CCA GAG
TGT). Polymerase chain reactions (PCRs) were performed on
50 ng of genomic DNA with a GeneAmp PCR system 9700
thermocycler  (Applied  Biosystems,  Foster  City,  CA)  and
correct temperatures for PCR. The PCR cycling conditions of
exons 4 and 5 consisted of an initial denaturation for 2 min at
95 °C followed by 30 cycles of denaturation for 30 s at 95 °C,
annealing for 30 s at 47.2 °C, extension for 40 s at 72 °C, and
a  final  extension  for  7  min  at  72  °C.  The  PCR  cycling
conditions of exon 10 were an initial denaturation for 2 min
at 95 °C followed by 35 cycles of denaturation for 30 s at
95 °C, annealing for 30 s at 52.3 °C, extension for 40 s at
72 °C, and a final extension for 7 min at 72 °C. Amplified
PCR products were separated by agarose gel electrophoresis
and visualized by staining with ethidium bromide. They were
then purified using purification columns (QIAquick; Qiagen,
Valencia, CA) and sequenced using dye terminator chemistry
(BigDye  Terminator  version  3.1  on  model  3100  Genetic
Analyzer; Applied Biosystems, Foster City, CA). Sequences
were trimmed for quality and aligned using BioEdit software
(version  5.0.6.  Copyright  ©1997–2001  Tom  Hall;  Ibis
Biosciences, Carlsbad, CA). Normal and affected individual
DNA sequences were aligned to the known reference genomic
sequence (NT_033899.7), which is available via the National
Center for Biotechnology Information (NCBI) database, and
compared for sequence variation.
Statistical  analysis:  To  examine  the  association  of  the
sequence  variants,  the  χ2  test  was  used  to  compare  the
alteration of genotypes between patients and control subjects.
This analysis evaluates the difference between the observed
genotype frequency and the expected frequency under the null
hypothesis of no association. However, when the expected
frequency is small, the Fisher exact test is conducted instead
[20]. Bonferroni correction was applied for the multiple tests.
Next, all detected sequence variants were assessed for Hardy–
Weinberg disequilibrium using χ2 test [20]. To evaluate the
effects of sequence variants on the risk of primary angle-
closure glaucoma, we conducted logistic regression analysis
with a stepwise approach [21]. The dependent variable was
the  disease  status  (patient,  1;  control  subject,  0),  and  the
independent  variables  were  values  of  sequence  variants
(homozygote, 2; heterozygote, 1; wild type, 0). The covariates
of interactions between sequence variants were also included
in the model. The final optimal model contains the statistically
significant  variables  that  were  selected  by  the  stepwise
procedure. These statistical analyses were performed using
SPSS software (ver. 10.1; SPSS Science, Chicago, IL). A p-
value less than 0.05 was considered statistically significant.
The  Haplo  stat  package  in  the  software  language  R
(version R 2.6.1) was used for haplotype analysis. Based on
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coefficients (Lewontin’s D′ and Hill’s r2) were obtained from
the  R  package  “genetics.”  The  Haploview  program  was
applied  to  estimate  pairwise  LD  between  markers  and
partition haplotype blocks. A pair of SNPs is identified to have
“strong LD” if the one-sided upper 95% CI boundary on D’
is greater than 0.98 and the lower boundary is greater than 0.7
[22].
RESULTS
In total, 63 patients with primary angle-closure glaucoma and
66 control subjects were enrolled in this study. There were 19
males and 44 females in the PACG group, and there were 42
males and 24 females in the control group. The mean age in
the  primary  angle-closure  glaucoma  patients  and  control
groups  were  60.04±9.91  years  and  59.12±6.75  years,
respectively  (p=0.547).  The  mean  axial  length  was
23.37±0.75 mm (ranged from 21.57 mm to 25.21 mm) for
right eyes and 23.32±0.76 mm (ranged from 21.35 mm to
24.63 mm) for left eyes of the control group (p=0.772). The
mean  axial  length  was  22.66±1.04  mm  (ranged  from
20.58  mm  to  25.92  mm)  for  eyes  with  an  attack  and
22.59±1.09 mm (ranged from 20.63 mm to 26.03 mm) for
fellow eyes in PACG subjects (p=0.731; Table 1).
Only  three  sequence  variants  were  identified  within
MFRP  for  all  the  cases  and  controls.  Sequence  variant
rs3814762  (A/G)  is  located  on  exon  4  and  leads  to  a
nonsynonymous  amino  acid  change  from  valine  to
methionine. Variants rs36015759 (T/C) and rs2510143 (C/T)
are both located on exon 5 and result in synonymous changes.
Allelic frequencies of the three sequence variants in cases
and controls are listed in Table 2. Although it was interesting
that there was a trend toward association (p=0.06) for SNP
rs36015759, no statistically significant association (χ2 test,
p>0.015) was observed in this SNP. The subjects used in this
study were justified by the Hardy–Weinberg’s exact test, and
there is no genetic bias in any of the SNPs. We also evaluated
the LD indexes for the specific LD block using three SNPs
around the MFRP gene region. The pairwise LD mapping
confirmed that these alleles have a comparatively strong LD
index greater than 0.7 for D′ and greater than 0.4 for r2 (Table
TABLE 1. AXIAL LENGTHS OF SUBJECTS WITH ACUTE PACG AND CONTROL GROUPS.
Axial Length (mm)
Attack eyes Fellow eyes Total eyes
PACG Subjects 22.66±1.04 22.59±1.09 22.63±1.07
Range 20.58-25.92 20.63-26.03 20.58-26.03
Control Subjects 23.34±0.75
Range 21.57-25.21
The difference of axial lengths of attacked eyes in acute PACG
groups  (63 eyes) and mean axial lengths of control subjects
(132 eyes) was tested statistically different with  t-test and p
value is 0.0001.
3  and  Table  4).  However,  there  were  still  no  statistically
significant associations observed in these haplotypes.
DISCUSSION
MFRP has been shown to be expressed in the retinal pigment
epithelium (RPE) of the eye [14], which makes it a possible
candidate gene for the regulation of axial length. In previous
studies, we have shown that a retino-scleral signaling cascade
may  explain  the  changes  in  the  scleral  structure  and
composition during ocular axial length regulation [23,24] in
which the RPE layer was proposed to transmit these signals
[25].
Sundin et al. [18] have found an association between
MFRP and nanophthalmos through a genetic linkage study.
In their study, nanophthalmos was found to segregate with
homozygous  null  mutations  in  MFRP  while  independent
frameshift  and  stop  codon  mutations  confirmed  the
association with nanophthalmos. MFRP null homozygotes
frequently develop angle-closure glaucoma, cystoid macular
edema, and serous retinal detachment, all conditions that are
often related to hyperopia and microphthalmia [18]. Pauer et
al.  [26]  have  also  observed  clinical  evidence  of  primary
photoreceptor  degeneration  in  MFRP  null  nanophthalmos
patients. Aung et al. [27] found that CHX10 and MFRP in
Chinese subjects in Singapore are not associated with primary
angle-closure glaucoma or with short axial length eyes.
In the present study, we found that MFRP revealed no
sequence  variants  that  would  implicate  this  gene  in  the
development of acute angle-closure glaucoma. In addition,
our haplotype association study of SNPs on MFRP did not
identify any significant association results for MFRP markers
in these phenotypes. Our results indicate that variations in
MFRP may not be a direct risk factor for acute angle-closure
glaucoma. It may be that MFRP is involved in some cases of
microphthalmia/anophthalmia but does not necessarily play a
role in the more common disease of angle-closure glaucoma.
Although the common link between the two disease states is
a small eye, in the case of microphthalmia or anophthalmia,
the defect is more extreme and present at birth.
The regulation of ocular axial length in patients who may
be at risk for angle closure is likely a complex process in which
other proteins may interact with MFRP and multiple genes
contribute to the growth process. For example, the COOH-
terminal domain of MFRP is known to be related to the Wnt-
binding CRD (cysteine-rich domain) of the frizzled family of
transmembrane  proteins  [28],  and  frizzled  proteins  are
receptors  for  the  Wnts,  a  family  of  cell–cell  signaling
molecules  that  mediate  the  regulation  of  growth,
differentiation, and cell polarity during development [29].
Secreted Frizzled-related proteins, which contain homologs
of the Wnt-binding CRD [30], are also thought to act as
competitive inhibitors of Wnt signaling, and a similar function
has been proposed for MFRP [15]. In this regard, we postulate
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.that MFRP can work with other proteins to regulate the size
of eyes, and specific sequence variations may not be necessary
for this regulation.
In animal models, there are many reports addressing the
role  of  MFRP  in  the  development  of  the  eye,  but  these
functions may not be equivalent in humans. For example, the
mouse mutant rd6 has also been mapped and identified as a
splice-site  mutation  in  the  orthologous  MFRP,  which  is
expressed in the retinal pigment epithelium (RPE) and ciliary
body of the mouse eye [15]. The rd6 mouse undergoes a slow
degeneration of photoreceptors, and during this process, the
fundus develops a distinctive array of depigmented spots that
bear  very  striking  resemblance  to  the  human  retinal
degenerative  disorders,  Stargardt  disease  and  fundus
albipunctatus. Although many mutations in the mouse are
known to cause microphthalmia, rd6 mice have never been
reported to have small eyes. This suggests that while the
mouse depends more heavily on MFRP for the maintenance
of photoreceptors, this gene is not used as part of a process of
post-natal  ocular  growth  since  this  process  of  secondary
ocular growth appears to be vestigial. The small eyes in angle-
closure glaucoma possess different anatomic features, which
in  most  cases  are  not  from  a  developmental  defect  of
nanophthalmos  and  microphthalmos  and  their  associated
anatomic features such as the unusual thickness of the choroid
and sclera [31].
The contents of the scleral coats will also likely play an
important role in extreme nanophthalmos and angle-closure
glaucoma. The sclera of the mammal is a typical fibrous
connective tissue consisting primarily of collagen in which
most  of  this  collagen  (as  much  as  99%)  is  type  I  [32].
However,  low  levels  of  other  fibrillar  collagen  subtypes
including type III, VI [33], XII [34], and V have been reported
in the mammalian sclera [33]. In our previous study, we could
not identify any associations of acute PACG with SNPs of
these collagen-associated genes [35]. Proteoglycans are also
a major component of the scleral ECM. The mammalian sclera
is  rich  in  hyaluronan,  a  unique,  non-sulfated
glycosaminoglycan that does not associate with a core protein
of its own. Sclera also contains large amounts of dermatan and
chondroitin sulfate-based proteoglycans [36], particularly the
small proteoglycans, decorin and biglycan [37,38]. However,
we also could not find any associations of keratocan, decorin,
and DSPG3 with acute PACG. The amino acid changes from
the SNPs of these proteoglycan genes are also not associated
with the anatomic changes of acute PACG. Interestingly, our
prior study revealed that SNP rs2664538, which is located
within MMP9, is likely to be associated with acute PACG. We
don’t fully understand the biological significance of this SNP
in the development of acute PACG. Further study will be
needed to identify additional potential candidate genes or
haplotypes for the development of angle-closure glaucoma,
which is strongly associated with small eye size.
In conclusion, sequence variants of MFRP do not appear
to be associated with a risk for acute angle-closure glaucoma.
Since  our  cohort  of  patients  with  an  acute  attack  had
significantly shorter eyes than the control group, our findings
suggest that MFRP is not primarily and directly involved in
ocular axial length regulation. However, there are still some
significant limitations in our current study. Although there are
a  substantial  number  of  patients  in  this  pilot  study,  it  is
underpowered to statistically rule out a potential association.
A multicenter study powered to have enough cases will be
needed to adequately study these and other MFRP SNPs for
their  possible  roles  in  the  development  of  acute  PACG.
Second, since the Han-Taiwanese population was used in this
study, the tagging SNPs in this group will be applied in a future
multicenter  study  instead  of  using  the  SNPs  of  other
populations. Because this was an exploratory pilot study, we
studied established SNPs from previous publications, which
TABLE 4. PAIRWISE LINKAGE DISEQUILIBRIUM ANALYSIS BETWEEN SELECTED SNPS OF MFRP.
rs36015759 rs2510143
rs36015759
D −0.0274
D' 0.9982
r −0.2009
χ2 10.4089
p value 0.0013
n 129
rs3814762
D −0.0386 −0.0093
D' 0.7138 0.3283
r −0.2163 −0.0675
χ2 12.0687 1.1757
p value 0.0005 0.2782
n 129 129
D: Linkage disequilibrium estimate; D': Scaled linkage disequilibrium estimate; r: Correlation coefficient; χ2: χ2 statistic for
linkage equilibrium; p value: χ2 p value for marker independence; n: Number of observations.
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1677showed biological significance. SNPs of MFRP have been
searched on HapMap to find possible tag SNPs in the Han-
Taiwanese population. There are six tag SNPs (rs948413,
rs948414, rs10790289, rs3814762, rs883247, and rs883245),
which  can  be  found  on  HapMap.  However,  the  SNPs
genotyped  in  Chinese-Han  are  rs11217241,  rs669462,
rs848413, rs948414, rs12294677, rs10790289, rs12421909,
rs2510143, rs3814762, rs4639950, rs883247, and rs883245
on HapMap. Among them, there are no sequence variants for
rs12294677, rs669462, and rs4639950 in the Han-Chinese
population.  rs3814762  is  the  selected  tag  SNP  from
HapMap, which is also the SNP used in this study. However,
there was no statistical difference of this SNP between “both
groups” in our study. We plan to use appropriate tagging SNPs
from HapMap and to genotype these variants in our future
study.  Furthermore,  the  tantalizing  level  of  association
(p=0.06) is very noteworthy, and it is of no major consequence
that it is a synonymous variant. The importance is that it may
actually be tagging a truly important functional variant. Future
studies evaluating the relationship of other genetic regulators
of axial length to MFRP may shed more light on its role in the
complex cascade of axial length determination.
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